Lipid exchange of apolipoprotein A-I amyloidogenic variants in reconstituted high-density lipoprotein with artificial membranes

被引:1
|
作者
Correa, Yubexi [1 ,2 ]
Ravel, Mathilde [1 ,2 ]
Imbert, Marie [1 ,2 ]
Waldie, Sarah [1 ,2 ]
Clifton, Luke [3 ]
Terry, Ann [4 ]
Roosen-Runge, Felix [1 ,2 ]
Lagerstedt, Jens O. [5 ,6 ]
Moir, Michael [7 ]
Darwish, Tamim [7 ,8 ]
Cardenas, Marite [1 ,2 ,9 ,10 ,11 ]
Del Giudice, Rita [1 ,2 ,12 ]
机构
[1] Malmo Univ, Biofilm Res Ctr Biointerfaces, Malmo, Sweden
[2] Malmo Univ, Fac Hlth & Soc, Dept Biomed Sci, Malmo, Sweden
[3] Harwell Sci & Innovat Campus, Sci & Technol Facil Council, Rutherford Appleton Lab, ISIS Pulsed Neutron & Muon Source, Didcot, England
[4] Lund Univ, MAX Lab 4, CoSAXS Beamline, Lund, Sweden
[5] Lund Univ, Diabet Ctr, Dept Clin Sci Malmo, Islet Cell Exocytosis, Malmo, Sweden
[6] Novo Nordisk, Rare Endocrine Disorders, Res & Early Dev, Copenhagen, Denmark
[7] Australian Nucl Sci & Technol Org ANSTO, Natl Deuterat Facil, Lucas Heights, NSW, Australia
[8] Univ Canberra, Fac Sci & Technol, Canberra, ACT, Australia
[9] Basque Fdn Sci, Ikerbasque, Bilbao, Spain
[10] Univ Basque Country, Biofis Inst, Leioa, Spain
[11] Malmo Univ, Biofilm Res Ctr Biointerfaces, S-20506 Malmo, Sweden
[12] Malmo Univ, Fac Hlth & Soc, Dept Biomed Sci, S-20506 Malmo, Sweden
关键词
amyloidogenic variants; apolipoprotein A-I; high-density lipoprotein; reconstituted HDL; X-RAY-SCATTERING; APOA-I; CHOLESTEROL; BILAYERS; ACID; CONFORMATIONS; MODEL; ORGANIZATION; BIOGENESIS; THERAPIES;
D O I
10.1002/pro.4987
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
High-density lipoproteins (HDLs) are responsible for removing cholesterol from arterial walls, through a process known as reverse cholesterol transport. The main protein in HDL, apolipoprotein A-I (ApoA-I), is essential to this process, and changes in its sequence significantly alter HDL structure and functions. ApoA-I amyloidogenic variants, associated with a particular hereditary degenerative disease, are particularly effective at facilitating cholesterol removal, thus protecting carriers from cardiovascular disease. Thus, it is conceivable that reconstituted HDL (rHDL) formulations containing ApoA-I proteins with functional/structural features similar to those of amyloidogenic variants hold potential as a promising therapeutic approach. Here we explored the effect of protein cargo and lipid composition on the function of rHDL containing one of the ApoA-I amyloidogenic variants G26R or L174S by Fourier transformed infrared spectroscopy and neutron reflectometry. Moreover, small-angle x-ray scattering uncovered the structural and functional differences between rHDL particles, which could help to comprehend higher cholesterol efflux activity and apparent lower phospholipid (PL) affinity. Our findings indicate distinct trends in lipid exchange (removal vs. deposition) capacities of various rHDL particles, with the rHDL containing the ApoA-I amyloidogenic variants showing a markedly lower ability to remove lipids from artificial membranes compared to the rHDL containing the native protein. This effect strongly depends on the level of PL unsaturation and on the particles' ultrastructure. The study highlights the importance of the protein cargo, along with lipid composition, in shaping rHDL structure, contributing to our understanding of lipid-protein interactions and their behavior.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] Apolipoprotein A-I mimetics and high-density lipoprotein function
    Gordon, Scott M.
    Davidson, William S.
    CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2012, 19 (02) : 109 - 114
  • [2] High-density lipoprotein subclasses and apolipoprotein A-I
    Duriez, P
    Fruchart, JC
    CLINICA CHIMICA ACTA, 1999, 286 (1-2) : 97 - 114
  • [3] High-density lipoprotein apolipoprotein A-I kinetics in obesity
    Ooi, EMM
    Watts, GF
    Farvid, MS
    Chan, DC
    Allen, MC
    Zilko, SR
    Barrett, PHR
    OBESITY RESEARCH, 2005, 13 (06): : 1008 - 1016
  • [4] The secondary structure of apolipoprotein A-I on 9.6-nm reconstituted high-density lipoprotein determined by EPR spectroscopy
    Oda, Michael N.
    Budamagunta, Madhu S.
    Borja, Mark S.
    Petrlova, Jitka
    Voss, John C.
    Lagerstedt, Jens O.
    FEBS JOURNAL, 2013, 280 (14) : 3416 - 3424
  • [5] Inhibition of Arthritis in the Lewis Rat by Apolipoprotein A-I and Reconstituted High-Density Lipoproteins
    Wu, Ben J.
    Ong, Kwok L.
    Shrestha, Sudichhya
    Chen, Kang
    Tabet, Fatiha
    Barter, Philip J.
    Rye, Kerry-Anne
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2014, 34 (03) : 543 - 551
  • [6] Differential impact of glycation on apolipoprotein A-I of high-density lipoprotein: a review
    Maarfi, Farah
    Ahmad, Saheem
    Alouffi, Sultan
    Akasha, Rihab
    Khan, M. Salman
    Rafi, Zeeshan
    Basnet, Hemashri
    Khan, Mohd Yasir
    GLYCOBIOLOGY, 2023, 33 (06) : 442 - 453
  • [7] Novel Pathways of Apolipoprotein A-I Metabolism in High-Density Lipoprotein of Different Sizes in Humans
    Mendivil, Carlos O.
    Furtado, Jeremy
    Morton, Allyson M.
    Wang, Liyun
    Sacks, Frank M.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2016, 36 (01) : 156 - 165
  • [8] Synthesis of recombinant high density lipoprotein with apolipoprotein A-I and apolipoprotein A-V
    Zhang, Xinbo
    Chen, Baosheng
    BIOLOGICAL CHEMISTRY, 2011, 392 (05) : 423 - 429
  • [9] Interfacial Properties of High-Density Lipoprotein-like Lipid Droplets with Different Lipid and Apolipoprotein A-I Compositions
    Koivuniemi, Artturi
    Sysi-Aho, Marko
    Oresic, Matej
    Ollila, Samuli
    BIOPHYSICAL JOURNAL, 2013, 104 (10) : 2193 - 2201
  • [10] Effects of atorvastatin on high-density lipoprotein apolipoprotein A-I metabolism in dogs
    Briand, F
    Magot, T
    Krempf, M
    Nguyen, P
    Ouguerram, K
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2006, 36 (04) : 224 - 230